Skip to main content

Table 2 HDL antioxidant enzyme activities and inflammatory markers

From: High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus

Characteristics

SLE patients (n = 51)

Controls (n = 49)

P Value

PON1 paraoxonase activity (U/l)

118.01 ± 85.49

124.68 ± 102.96

0.857

PON1 arylesterase activity (U/l)

125.65 ± 26.87

148.35 ± 39.34

0.001

Paraoxonase activity/HDL

98.48 ± 69.92

76.20 ± 64.34

0.025

Arylesterase activity/HDL

109.05 ± 38.23

93.51 ± 33.30

0.036

Total HDL antioxidant capacity (%)

165.82 ± 58.28

217.71 ± 54.36

<0.001

OxLDL (mg/l)

3.55 ± 4.19

2.63 ± 3.22

0.291

HsCRP (mg/l)

5.02 ± 6.64

1.68 ± 1.88

0.002

ESR (mm/hour)

24.38 ± 17.96

7.90 ± 5.93

<0.001

IL-6 (ng/l)

0.54 (0–3.25)

0 (0–0.17)

0.002

SAA (ug/l)

19017.07 ± 25899.25

2666.05 ± 2301.11

<0.001

MCP-1 (ng/l)

473.24 (342.72-599.16)

309.72 (242.91-353.86)

<0.001

SAA/HDL (ug/mmol)

18217.14 ± 29453.17

1692.24 ± 1459.34

<0.001

  1. ESR erythrocyte sedimentation rate; HDL high-density lipoprotein; hsCRP high-sensitivity C-reactive protein; IL-6 interleukin-6; MCP-1 monocyte chemoattractant protein-1; ox-LDL oxidized low-density lipoprotein; PON1 paraoxonase-1; SAA serum amyloid A
  2. Statistically significant differences are marked in bold